cancer-gi-cancer-digestive-2018-keynote

13 / 20

Page 51
Notes:
Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8
&
&
October 29-30, 2018 | San Francisco, USA
International Conference on
Gastrointestinal Cancer and Therapeutics
4th World Congress on
Digestive & Metabolic Diseases
26th Annual Congress on
Cancer Science and Targeted Therapies
Observational clinical study to note the impact of the ayurvedic mineral complex in pancreatitis patients
Pancreatitis, an inflammatory disorder of pancreas, is mainly categorized into acute and chronic form. While chronic
pancreatitis is irreversible and progressive, even a single attack of acute pancreatitis can convert into chronic pancreatitis.
The disease brings substantial physical, emotional, psychological and financial burden to patients and their families due to
its unpredictable nature. The disease is also associated with early mortality. India reportedly has the highest incidences of
pancreatitis. Owing to the limitations of modern medicine, many patients of pancreatitis turn to alternative and complementary
medicine. In India, it is more so where many alternative systems of medicines are officially recognized as independent medical
systems along with modern medicine. An Ayurvedic Mineral Complex (AMC) developed by an Ayurvedic physician brought
miraculous recovery in a terminally ill patient of pancreatic cancer. The same formulation also showed repeated success in
treating Pancreatitis patients. The practice was subjected to documentation following Good Clinical Practice guidelines since
1997. Till date, nearly 620 well-diagnosed cases of pancreatitis have opted for this treatment at their own expense. Results
indicate that AMC brings significant reduction in weight loss, number of attacks and hospitalizations and improves weight.
The patients were off all pancreatic enzymes after the start of Ayurvedic treatment. Safety studies have shown that AMC causes
no Grade II toxicity. In an experimental study, AMC has shown a significant protective effect in animal models of pancreatitis.
There is strong Prima facie that AMC brings sustainable complete relief to pancreatitis patients. However, further studies are
required for understanding and development of the formulation.
Biography
Vaidya Balendu Prakash, born on March 14, 1959, at Meerut. He completed his university graduation in Science and Ayurveda medicine, learned applied aspects of
Rasa Shastra from his father Vaidya Chandra Prakash, set up Vaidya Chandra Prakash Cancer Research Foundation (SIROs) to carry basic research in Ayurveda
under the patronage of Late Dr KR Narayanan (Former President of India). He is the first and only Ayurvedic physician to get the Life Membership of Indian Co-
operative Oncology Network (ICON) and is a member of the International Headache Society (IHS), UK.
Vaidya Balendu Prakash
VCPC Research Foundation, India
Vaidya Balendu Prakash, J Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C8-084